ASSOCIATION BETWEEN POLYMORPHIC MARKERS OF THE IL4 (с-590Т) AND IL10 (с-597А) GENES AND PSORIATIC ARTHRITIS

QR Code

ASSOCIATION BETWEEN POLYMORPHIC MARKERS OF THE IL4 (с-590Т) AND IL10 (с-597А) GENES AND PSORIATIC ARTHRITIS

Psoriatic arthritis is a chronic progressive disease of joints developing along with psoriasis. Likewise arthritis and psoriasis alone, it represents the systemic multifactorial disease of unknown etiology; therefore prevention of the disease is inefficient. Genetic predisposition to psoriatic arthr...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Smolnikova, S. V. Smirnova
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2012-05-01
Series:	Acta Biomedica Scientifica
Subjects:	genes polymorphism psoriatic arthritis interleukin
Online Access:	https://www.actabiomedica.ru/jour/article/view/915
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The frequency of distribution of the genotypes of the IL4 polymorphism (rs 2243250) in psoriasis and psoriatic arthritis
by: A. A. Barilo, et al.
Published: (2019-02-01)

GENETIC FACTORS IN IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: M. V. Smolnikova, et al.
Published: (2014-08-01)

PROGNOSIS FOR PREDISPOSAL TO DEVELOPMENT OF VIRAL HEPATITIS C BASED ON G-308A TNFА, T-330G IL-2, С-590Т IL-4, С-703Т IL-5, AND C-592A IL-10 GENE POLYMORPHISMS
by: V. V. Avdoshina, et al.
Published: (2014-07-01)

THE ROLE OF GENETIC POLYMORPHISMS OF GENE IL-1β (-31 Т/С) AND IL-6 (-174 G/C) IN THE COURSE OF CHRONIC HEPATITIS B AND C IN CHILDREN
by: S. V. Romanova, et al.
Published: (2014-07-01)

ASSOCIATION OF IL-1β, IL-4 AND IL-6 GENES POLYMORPHISMS WITH GENETIC PREDISPOSITION FOR AUTOIMMUNE THYROIDITIS
by: E. M. Biktagirova, et al.
Published: (2014-07-01)

Ixekizumab in the treatment of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2024-12-01)

AGE-DEPENDENT INDEXES OF IMMUNITY IN THE PATIENTS WITH PSORIATIC ARTHRITIS
by: A. A. Barilo, et al.
Published: (2019-01-01)

IL-8 CHEMOTACTIC FACTOR IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA AND FEATURES OF IL-8 GENE POLYMORPHISM (251 T/А)
by: L. F. Aznabaeva, et al.
Published: (2014-07-01)

Value of polymorphism of a gene of interleukin-17 (П-17а g-197a, il-17f his161arg) in a pathogenesis of the influenza IN children
by: N. A. Miromanova
Published: (2013-11-01)

Prospects for the use of monoclonal antibodies to interleukin 23 Gusеlkumab in psoriatic arthritis: New data
by: E. L. Nasonov, et al.
Published: (2022-03-01)

Search for genetic markers of predisposition to psoriasis and psoriatic arthritis
by: M. V. Smolnikova, et al.
Published: (2020-12-01)

Effect of IL-7 and IL-7R blockade on cytokine production by peripheral blood t cells from patients with psoriatic arthritis
by: E. A. Blinova, et al.
Published: (2024-09-01)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: S. V. Smirnova, et al.
Published: (2014-08-01)

Genetic polymorphism of xenobiotic biotransformation genes, TNF-α and IL-4 in obstructive jaundice
by: A. A. Natalsky, et al.
Published: (2015-09-01)

Efficacy and safety of netakimab in patients with psoriatic arthritis: results of the phase III PATERA clinical study
by: T. V. Korotaeva, et al.
Published: (2020-11-01)

The role of polymorphism of genes IL5 (–703) and IL5RA (–80) in formation of blood eosinophilia under pulmonary tuberculosis
by: K. O. Mikheyeva, et al.
Published: (2012-08-01)

Evaluation of the levels of interleukins IL-4, IL-13, IL-5, IL-10 and IL-33 in atopic dermatitis patients with and without dupilumab therapy
by: Jarmila Čelakovská, et al.
Published: (2025-07-01)

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)

Efficacy of netakimab in key psoriatic arthritis domains: 54-week results from the phase III BCD-085-8/PATERA study
by: T. V. Korotaeva, et al.
Published: (2021-03-01)

Netakimab for the treatment of psoriatic arthritis: 3-year results of the phase III BCD-085-8/PATERA study
by: T. V. Korotaeva, et al.
Published: (2024-08-01)

Use of the interleukin-17A inhibitor secukinumab in psoriatic arthritis: a subanalysis of the Russian population in the international randomized clinical trials FUTURE 1 and FUTURE 2
by: T. V. Korotaeva, et al.
Published: (2017-04-01)

Difficult-to-treat psoriatic arthritis. Data from the All-Russian registry of patients with psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2024-10-01)

Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry
by: E. E. Gubar, et al.
Published: (2021-10-01)

CLINICAL HETEROGENEITY OF EARLY PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2016-12-01)

PECULIARITIES OF AN ASSOCIATION OF POLYMORPHOUS MARKERS -251 Т>А OF IL-8 GENE AND POLYMORPHISM OF HELICOBACTER PYLORI GENES IN NATIVE AND VISITANT POPULATION OF THE REPUBLIC OF KHAKASSIA
by: E. S. Ageeva, et al.
Published: (2012-04-01)

PROMOTOR POLYMORPHISM OF IL-4, IL-6, AND IL-10 GENES AMONG PATIENTS WITH BREAST CANCER
by: A. V. Shevchenko, et al.
Published: (2014-07-01)

IL-31 and IL-33 in rheumatoid arthritis patients
by: N. A. Lapkina, et al.
Published: (2022-11-01)

PROSPECTS FOR USING INTERLEUKIN-17 INHIBITORS, A NEW CLASS OF DRUGS FOR TARGETED THERAPY OF PSORIATIC ARTHRITIS
by: T. V. Korotaeva
Published: (2016-07-01)

COMBINATION ANALYSIS OF CYTOKINE GENE PROMOTER POLYMORPHISMS OF IL1B T-31C, IL-6 G-174C, TNFA G-238A, TNFA G-308A, TNFA C-863A, IL4 C-590T, IL-10 C-592A FOR PREDICTION OF TREATMENT EFFICIENCY IN RHEUMATOID ARTHRITIS
by: V. I. Konenkov, et al.
Published: (2014-07-01)

ANALYSIS OF ASSOCIATIONS BETWEEN PROMOTER ALLELES OF TNFA, IL2. IL4 AND IL10, AND PARAMETERS OF IMMUNE SYSTEM IN HIV-INFECTED PATIENTS
by: M. V. Smolnikova, et al.
Published: (2014-07-01)

ASSOCIATION OF rs4537545 (C>T) ALLELE POLYMORPHISM IN THE IL6R GENE WITH THE DEVELOPMENT OF RHEUMATOID ARTHRITIS
by: L. V. Topchieva, et al.
Published: (2020-06-01)

TREAT-TO-TARGET STRATEGY FOR EARLY PSORIATIC ARTHRITIS (PRELIMINARY RESULTS OF THE REMARCА STUDY)
by: T. V. Korotaeva, et al.
Published: (2014-09-01)

TREAT-TO-TARGET STRATEGY FOR EARLY PSORIATIC ARTHRITIS (PRELIMINARY RESULTS OF THE REMARCА STUDY)
by: T. V. Korotaeva, et al.
Published: (2016-12-01)

Clinical and instrumental characteristics of axial psoriatic arthritis in combination with hyperuricemia
by: Yu. L. Korsakova, et al.
Published: (2024-08-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2016-09-01)

Platelet functions in healthy persons with genetic polymorphisms gpia(с807т), gpiiia(т1565с), gpipa(с434т), p2ry12(н1/н2), selp(-g1087a) platelet receptions
by: N. N. Strambovskaya
Published: (2013-11-01)

Inhibitors of interleukin 17A in the treatment of psoriatic arthritis: what's new?
by: Т. V. Korotaeva
Published: (2021-04-01)

Updated international recommendations (EULAR, 2023) for the treatment of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2024-11-01)

Relationship between IL1B gene polymorphism and smoking with the risk of myocardial infarction
by: M. V. Khutornaya, et al.
Published: (2014-09-01)